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Introduction
An important feature of nanotechnology concerns 
the development of experimental procedure for the 
arrangement of a nanoscale materials with special 
properties (Murray et al., 2000). Although different 
procedures for assembly of nanomaterials have been 
extended, in recent years production of nanoparticles 
(NPs) by bio-mimetic methods, as novel techniques, 
has been an attractive subject with increasing attention 
(Mandal et al., 2006). Furthermore, growing demands to 
expand green chemistry for nanomaterial synthesis has 
resulted in researchers focusing on biosynthetic methods 
(Mohanpuria et al., 2008). Among these methods, green 
synthesis of NPs by biological organisms such as bacteria 
can participate with other methods attributable to its 
clean, nontoxic and eco-friendly aspects (Bhattacharya 
& Gupta, 2005). Some micro-organisms have good 
potential to reduce different metal and metalloid ions 
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Context: In the present investigation, acute and subacute toxicity of the biogenic Se nanoparticles (Se NPs) has been 
reported.
Objective: To characterize the Se NPs produced by a bacterium species and to evaluate their toxicity and impact on 
clinical chemistry and hematological parameters of NMRI mice.
Materials and methods: The Se NPs were prepared by Bacillus sp. MSh-1 in a culture medium containing SeO2 
(1.26 mM) and their physiochemical properties investigated using TEM, XRD and FT-IR. The LD50 of Se NPs and SeO2 
were determined and the subacute toxicity evaluated by orally administration of 0, 2.5, 5, 10 and 20 mg kg−1 of Se NPs 
to male mice for 14 consecutive days. Parameters of blood cells, AST, ALT, ALP, creatinine, BUN, cholesterol, bilirubin, 
triglyceride and CPK were experimentally measured.
Results: The XRD and TEM analyses showed that the spherical NPs were amorphous, in the size range of 80–220 nm. 
The toxicological evaluation showed that the LD50 values of SeO2 and Se NPs were 7.3 and 198.1 mg kg
−1, respectively. 
No biochemical changes were observed from the administration of 2.5, 5 and 10 mg kg−1 of Se NPs, but a dose of 
20 mg kg−1 was accompanied with signs of toxicity including lower body weight and changes in clinical chemistry 
and hematological parameters.
Conclusion: The biogenic Se NPs were less toxic than synthetic Se NPs and much less (26-fold) toxic than the SeO2, 
which demonstrates the important role of Bacillus sp. MSh-1 in conversion of a highly toxic Se compound to the less 
toxic Se NPs.
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to nanoparticles and the ability of various bacterias to 
reduce selenium ions have been previously reported 
(Kessi et al., 1999; Yee et al., 2007; Jafari-Fesharaki et 
al., 2010). However, limited research has been reported 
on the isolation, characterization and employment of 
the biogenic Se NPs for various applications. On the 
other hand, nanotoxicology is rising as an important 
part of nanotechnology and the majority of studies in 
this field have focused on health effects of exposure to 
nanoparticles (Fischer & Chan, 2007; Aillon et al., 2009).
Selenium is a micronutrient metalloid element with 
broad functions in biologic systems, including antioxi-
dant effects, immune modulation, cancer prevention and 
antiviral activities (Beck et al., 2003; Hoffmann & Berry, 
2008; Zeng & Combs, 2008). There is a very thin border 
between the lowest acceptable levels of intake and toxic-
ity (Schrauzer & Surai, 2009). Selenium toxicity is related 
to chemical forms in which exposure to selenious acid 
or selenium oxide has caused serious toxicity (Köppel 
et al., 1986). Oxidation states of selenium including sel-
enate (Se+6), selenite (Se+4), selenide (Se−2) and elemental 
selenium (Se0) are commonly found in the environment. 
Generally, Se0 is prepared on a nanoscale by reduction of 
higher oxidation states to other allotropic forms (Yang et 
al., 2008; Raevskaya et al., 2008).
Elemental selenium at the redox state of zero is insol-
uble in aqueous media and generally considered to be 
biologically inert (Zhang et al., 2005). In addition, based 
on several in vivo and in vitro studies, the lower toxicity 
of synthetic elemental selenium in comparison to other 
oxidative states has previously been established (Zhang 
et al., 2001, 2007). Some animal studies have indicated 
that liver is the main target organ of selenium toxicity 
(Diskin et al., 1979). Damage to the structural integrity of 
the liver is assessed by elevated serum levels of enzymes 
such as ALT, AST and ALP. Nevertheless, there is no report 
on the acute lethal dose of the biogenic Se NPs as novel 
nanoparticles derived from bacteria.
In this investigation, we prepared biogenic Se NPs by 
employing the Bacillus sp. MSh-1 as a potent bacterium 
in selenium reduction. In the next step, cells containing 
intracellular Se NPs were disrupted by the liquid nitro-
gen method. Subsequently, to separate and purify Se 
NPs from the whole-cell lysate, we used a liquid-liquid 
two phase partitioning method. After characterization 
of the purified Se NPs, the median lethal dose of the Se 
NPs were determined in mice and compared with sele-
nium dioxide. Finally, the subacute toxicity of Se NPs was 
tested by measuring serum biochemical parameters.
Materials and methods
Materials
Selenium dioxide (SeO
2
), nutrient broth, nutrient agar, 
n-octyl alcohol, sodium dodecyl sulfate (SDS) and Tris 
base were purchased from Merck Chemicals (Germany). 
All other chemicals and solvents were of analytical grade. 
The micro-organism used in this study was identified 
as Bacillus sp. MSh-1 by the methods described earlier 
(Shakibaie et al., 2010). The organism was continuously 
conserved on nutrient agar plates complemented with 
the 1.26 mM SeO
2
 using continuous sub-culturing every 
14 days.
Biosynthesis of Se NPs
Synthesis of Se NPs was carried out by Bacillus sp. MSh-1 
using a recently described method (Shakibaie et al., 2010). 
Nutrient broth was supplemented with Se4+ ions (100 mg 
L−1; which is equal to 1.26 mM SeO
2
) and sterilized by a 
filtration process using a Millipore filter apparatus (0.22 
µm). The medium was inoculated (1% v/v) with the fresh 
inoculums (OD
600
, 0.1) and for aerobic cultivation; the 
flasks were plugged with cotton and incubated at 30°C in 
a shaker incubator (150 rpm). In a similar trial, inoculated 
media without Se4+ ions were used as controls. After 14 h, 
the bacterial cells and Se NPs were removed from the cul-
ture medium by centrifugation at 4000g for 10 min. Red is 
the color of precipitated Se0 NPs, thus serving as a provi-
sional marker in which micro-organism reduces the Se4+ 
ions to Se NPs (Oremland et al., 2004).
Isolation and recovery of the Se NPs
The resulting pellets were washed with 0.9% NaCl solu-
tion, centrifuged and transferred to a mortar. By adding 
liquid nitrogen, the pellets were frozen and disrupted with 
a pestle. The resulting slurry was ultrasonicated at 100 W 
for 5 min and washed three times by sequential centrifu-
gation (10000g, 5 min) using Tris-HCl buffer (1.5 M, pH 
8.3) containing 1% sodium dodecyl sulfate (SDS) and 
deionized water, respectively. The pellets were suspended 
in deionized water, and the resulting suspension contain-
ing Se NPs and cell debris was collected. The suspension 
(4 mL) was then transferred to test tubes, and 2 mL of 
n-octyl alcohol was added to each tube. The assortments 
were shaken vigorously, the mixed phases were separated 
by centrifugation at 2000g for 5 min and were stored at 
4°C for 24 h. Following the time period, the generated Se 
NPs can be observed at the bottom of the tubes and the 
cell debris remained between two phases. The lower 
and upper phases were discarded, and settled NPs were 
washed with chloroform, ethyl alcohol and distilled water, 
respectively (Shakibaie et al., 2010). For further character-
izations and biological experiments, the cleaned NPs were 
then resuspended in deionized water and stored at 4°C.
Characterization of the Se NPs
The properties of Se NPs were further confirmed using a 
number of instrumental techniques. For transmission 
electron microscopy, an aqueous suspension containing 
the Se NPs was dispersed ultrasonically, and a drop of the 
suspension was placed on carbon-coated copper TEM 
(transmission electron microscope) grids and dried under 
an IR lamp. Micrographs were obtained using a TEM 
(Zeiss 902A) operated at an accelerating voltage of 80 kV. 
Related size distribution pattern of Se NPs was plotted by 
manual counting of 200 individual particles from different 
Ph
ar
m
ac
eu
tic
al
 B
io
lo
gy
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
80
.1
91
.1
65
.2
00
 o
n 
01
/0
7/
13
Fo
r p
er
so
na
l u
se
 o
nl
y.
60 M. Shakibaie et al.
  Pharmaceutical Biology
TEM images. The crystalline structure of the Se NPs was 
checked by the XRD (X-ray diffraction) technique using an 
X-ray diffractometer (Philips PW1710) with CuKα radia-
tion (λ = 1.5405 Å) over a scanning range of Bragg angles 
from 20° to 80°. The surface chemistry of oven-dried Se 
NPs (37°C, 48 h) extracted with the two solvent phase sys-
tem has been also investigated by Fourier transform infra-
red (FT-IR) with a infrared spectrophotometer (Shimadzu 
IR-470, Japan) at a resolution of 4 cm−1 in KBr pellet.
Animals and treatments
Male NMRI mice (body weight 22 ± 2 g) were used in 
this study. The mice were purchased from the Pasteur 
Institute of Iran (Tehran, Iran) and were housed in plastic 
cages (four to six each) in a colony room with controlled 
temperature (22 ± 1°C) and humidity (50 ± 10%) with a 
12/12 h light/dark cycle. The mice had free access to tap 
water and food. The experimental procedures carried out 
in this study were in compliance with the guidelines of 
the Tehran University of Medical Science (Tehran, Iran) 
for the care and use of laboratory animals.
Acute toxicity
Ninety six mice were randomly divided into 12 groups 
with 8 mice per group. A bolus of selenium dioxide and 
Se NPs dispersed in 0.9% apyrogenic sterile NaCl was 
administered orally by gavage at the doses indicated in 
Table 1. In a similar trial, the control group received 0.9% 
apyrogenic sterile NaCl. The animals were observed for 
viability and clinical signs of toxicity on the day of dosing 
and then daily for 14 days. Cumulative mortality within 
24 h after the treatment was used for the calculation of 
median lethal dose (LD
50
).
Evaluation of subacute toxicity
Fifty mice were randomly divided into five groups with 10 
mice per group. The first group (control) was administrated 
0.9% saline orally (PO), and the second to fifth groups were 
orally administrated Se NPs at the doses of 2.5, 5, 10 and 
20 mg kg−1, respectively, for 14 consecutive days.
Determination of clinical chemistry and  
hematological parameters
Following the experimental period, animals were fasted 
overnight and anaesthetized by Ketamine-Xylizine, 
then the abdomen was opened, and blood samples were 
collected from the heart. For hematological studies, 
total blood was collected into tubes containing ethyl-
enediamine tetraacetic acid (EDTA) anticoagulant, and 
biochemical parameters, including hemoglobin, hema-
tocrit, white blood cell counts, red blood cell counts, 
and platelet counts were measured. To measure clinical 
chemistry parameters in serum, blood was collected 
into tubes containing no anticoagulant, allowed to clot, 
and serum was separated by centrifugation at 2000g for 
20 min. The assays of aspartate amino transferase (AST), 
alanine amino transferase (ALT), alkaline phosphatase 
(ALP), creatinine, BUN, cholesterol, bilirubin (direct 
and total), triglyceride and creatine phosphokinase 
(CPK) were performed using Ellitech diagnostic kits 
(Sees, France).
Statistical analysis
The results were presented as mean ± SE. The differ-
ence between groups was evaluated by ANOVA which 
followed by Tukey test and p values less than 0.05 were 
considered significant.
Results
Green synthesis
Bacillus sp. MSh-1 culture exhibited a gradual change in 
color toward red when it was incubated with SeO
2
. As a 
result of the Se+4 ions reduction to Se0 nanoparticles, the 
color of inoculated nutrient broth media was changed 
to intense red after 14 h of incubation at 30°C. Control 
(inoculated media without Se+4 ions) did not exhibit 
any color change of the culture media. According to 
Figure 1, which shows the TEM image, Se NPs have a 
spherical shape. The TEM micrograph clearly illustrates 
individual Se NPs with a small amount of aggregation. 
Size distribution measured from manual counting of 200 
individual particles from different TEM images showed 
that the NPs with the size of 105 to 130 nm had the most 
frequency. Figure 2 shows the X-ray diffraction profile of 
Figure 1. Transmission electron micrograph of the purified 
biogenic Se NPs synthesized by Bacillus sp. MSh-1.
Table 1. Acute lethal effect of selenium dioxide and biogenic Se 
NPs in mice.
SeO
2
Biogenic Se NPs
Se dose 
(mg kg−1)
Mouse mortality 
(%)
Se dose  
(mg kg−1)
Mouse mortality  
(%)
2 12.5 120 12.5
6 25 160 37.5
10 7.35 198.1 50
14 75 240 62.5
18 87.5 280 75
22 100 320 100
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Se NPs synthesized using Bacillus sp. MSh-1. The XRD 
pattern of Se NPs showed the presence of broad peaks 
without any clear lattice parameters. FTIR spectrum 
of Se NPs showed main peaks at 3462 and 1663 cm−1. A 
strong peak at 3462 cm−1 could correspond to O-H or N-H 
and this indicated an alcohol or N-H containing amide, 
while the strong peak at 1663 cm−1 could be related to a 
carbonyl group (Figure 3). These results might be attrib-
utable to the connection of proteins on the surface of 
nanoparticles during the formation of the Se NPs.
Acute lethal dose (LD
50
)
Table 1 shows the result of acute Se NPs and SeO
2
 toxicity 
in mice. SeO
2
 caused complete mortality at the dose of 
24 mg kg−1. However, biogenic Se NPs showed no acute 
toxicity at this dose. According to the data presented in 
Table 1, the LD
50
 of SeO
2
 and Se NPs were 7.35 mg kg−1 
(with 95% confidence limits of 4.39–10.38 mg kg−1) and 
194.6 mg kg−1 (with 95% confidence limits of 152.4–
242.29 mg kg−1), respectively.
Clinical chemistry and hematology parameters 
determination
Based on the results for acute lethal dose (LD
50
), doses 
of 2.5, 5, 10 and 20 mg kg−1 of Se NPs were chosen. No 
death was observed in doses of 2.5, 5 and 10 mg kg−1, 
while 20% death was observed in the group receiving 
20 mg kg−1 of Se NPs. The results of the clinical chemistry 
and hematological parameters following Se NPs admin-
istration (14 days) are presented in Tables 2 and 3. No 
change was found attributed to the administration of Se 
NPs at the employed doses of 2.5, 5 and 10 mg kg−1 over 
the control.
Body weight
Mean body weights were shown in Figure 4. The body 
weight of male mice receiving Se NPs at the dose of 
20 mg kg−1 were significantly decreased (p < 0.05), but in 
other groups, similar to control, body weights increased 
daily.
Discussion
In this study, Se NPs were prepared by a previously 
isolated bacterium (Bacillus sp. MSh-1) (Shakibaie 
et al., 2010), purified and their properties were confirmed 
using a number of instrumental techniques. The purified 
Se NPs exhibited a relatively wide size range between 80 
and 220 nm. Also, biogenic Se NPs prepared by Bacillus 
sp. MSh-1 did not show any clear lattice parameters in 
XRD pattern, thus classified as amorphous materials 
(Figure 2). FTIR measurements of Se NPs were applied 
to identify the functional group existing on the surface of 
nanoparticles. In biological systems, such as Bacillus sp. 
MSh-1, while the Se NPs are grown under the reductive 
reactions, some compounds might be entrapped within 
the layers and their functional groups were exposed in 
the surface of the nanoparticles (Figure 3). As a novel 
idea in further studies, each of the mentioned functional 
groups existing on the surface of the nanoparticles could 
be used for the formation of covalent binding between 
the various active compounds and biogenic nanopar-
ticles. While the lower toxicity of the synthetic Se NPs 
has been previously reported, in comparison to other 
selenium compounds such as selenomethionine (Zhang 
et al., 2008), to the best of our knowledge and according 
to a survey of the literature, no report is available on the 
acute lethal effect of biologic Se NPs. Comparing the mea-
sured LD
50
 for SeO
2
 and biogenic Se NPs revealed that the 
Bacillus sp. MSh-1 converts the soluble SeO
2
 to insoluble 
Se particles at nano size which are approximately 26-fold 
less toxic in mice (LD
50
 198.1 and 7.35 mg kg−1, respec-
tively). Zhang et al. reported that their synthetic Se NPs 
have a 7-fold lower acute toxicity than sodium selenite 
in Kunming mice (LD
50
 113 and 15 mg kg−1, respectively) 
(Zhang et al., 2001). Furthermore, Wang et al. reported 
that their Se NPs have a 3.5-fold lower acute toxicity 
than selenomethionine in Kunming mice (LD
50
 92.1 and 
Figure 2. X-ray diffraction patterns of biogenic Se NPs.
Figure 3. Fourier transform infrared (FTIR) spectrum of Se NPs.
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25.6 mg kg−1, respectively) (Wang et al., 2007). It seems 
that the chemical form, oxidative state and solubility of 
the selenium compounds play an important role in the 
acute toxicity of selenium.
Growth retardation is a main characteristic in 
selenium-intoxicated animals in which the American 
National Research Council concluded that inhibition of 
growth might be the best indicator for the toxic effects of 
selenium (Thorlacius-Ussing, 1990; Orskov & Flyvbjerg, 
2000). In the present study, Se NPs at the dose of 20 mg 
kg−1 significantly reduced body weight of mice, while 
body weight of the animals receiving Se NPs at the doses 
of 2.5, 5 and 10 mg kg−1 were increased similar to the con-
trols (Figure 4). Se causes growth retardation by reduc-
ing growth hormone and somatomedin C production 
(Köppel et al., 1986), insulin-like growth factor-binding 
proteins and insulin-like growth factor-I (Grønbaek et al., 
1995).
Liver enzyme activities such as ALT, AST and ALP are 
the major characteristics of liver function. Continuous 14 
days administration of Se NPs at the doses of 2.5, 5 and 
10 mg kg−1 caused no significant change on liver func-
tions (p > 0.05). In addition, no change in levels of cre-
atine phosphokinase (CPK), blood urea nitrogen (BUN) 
and creatinine was observed. Similarly, other clinical 
chemistry parameters, including hemoglobin, hemato-
crit, bilirubin, cholesterol, triglyceride, white blood cell 
counts, red blood cell counts and platelet counts were at 
normal ranges in Se NPs treated groups at the doses of 
2.5, 5 and 10 mg kg−1 with no significant difference.
At the dose of 2.5 mg kg−1, Selenium dioxide (SeO
2
) 
caused a high death rate in the subacute study, while at the 
similar dose with biogenic Se NPs, no death was observed. 
The surviving animals in the SeO
2
 group showed clinical 
symptoms of poisoning, including skin color change and 
lower mobility, appetite and body weight.
Table 2. Clinical chemistry parameters in serum.
Clinical chemistry 
parameters Control Se NPs (2.5 mg kg−1) Se NPs (5 mg kg−1) Se NPs (10 mg kg−1) Se NPs (20 mg kg−1)
AST (U/L) 154.6 ± 26.2 155 ± 20.4 160.75 ± 18.7 171.5 ± 21.8 214.7 ± 23.9*
ALT (U/L) 56.25 ± 11.4 59.2 ± 6. 6 64.8 ± 9. 3 73.25 ± 11.4 89.5 ± 12.3*
ALP (U/L) 111.6 ± 31.3 117 ± 15.1 125 ± 22.4 131.75 ± 23.3 190.8 ± 35.7*
Cr (mg/dL) 0.175 ± 0.02 0.176 ± 0.02 0.18 ± 0.03 0.183 ± 0.04 0.25 ± 0.04*
BUN (mg/dL) 25.8 ± 3.9 28.25 ± 3.6 30.25 ± 4.1 31.8 ± 4.4 37.8 ± 4.6*
Chol (mg/dL) 114.6 ± 7.21 114.6 ± 7.2 115.25 ± 8.6 119.6 ± 8.9 131.6 ± 9.8*
TG (mg/dL) 54.6 ± 4.88 59.4 ± 5.65 62.75 ± 6.6 68.25 ± 7.9 88.25 ± 8.8*
CPK (U/L) 150.4 ± 15.39 153 ± 15.34 156.5 ± 14.93 161.4 ± 16.61 188.4 ± 17.61*
TB (mg/dL) 0.12 ± 0.02 0.125 ± 0.02 0.13 ± 0.02 0.141 ± 0.03 0.175 ± 0.05*
ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; BUN, Blood urea nitrogen; FBS, fasting blood 
sugar; Chol, cholesterol; Cr, creatinine; CPK, creatine phosphokinase; TG, triglyceride; TB, bilirubin (total).
*p < 0.05, significantly different when compared with control.
Mice were administered Se NPs at the doses of 2.5, 5, 10 and 20 mg/kg for 14 consecutive days. No significant differences have been 
observed between the three experiment doses of 2.5, 5 and 10 mg/kg of mice groups as compared to control. All data are given as mean ± SE 
(n = 10), as compared with the controls.
Table 3. Hematology parameters in total blood.
Hematology 
parameters Control Se NPs(2.5 mg kg−1) Se NPs (5 mg kg−1) Se NPs (10 mg kg−1) Se NPs (20 mg kg−1)
WBC (×l03/µL) 2.2 ± 0.3 2.33 ± 0.4 2.9 ± 0.6 3.13 ± 0.5 4.1 ± 0.6*
HGB (g/dL) 10.4 ± 3.3 10.7 ± 3.9 11.1 ± 3.8 11.5 ± 4.1 17.7 ± 4.9*
RBC (×l06/µL) 6.82 ± 1.2 6.87 ± 1.4 7.24 ± 1.3 7.33 ± 1.4 10.72 ± 2.4*
PLT (×l03/µL) 926.1 ± 177.4 1012.2 ± 168.4 1111.7 ± 206.3 1243.3 ± 179.8 1302.6 ± 188.4*
Hct (%) 31.2 ± 11.6 31.6 ± 10.8 36.3 ± 10.9 37.2 ± 11.4 56.6 ± 12.8*
WBC, white blood cell count; HGB, hemoglobin; RBC, red blood cell count; PLT, platelet count; Hct, hematocrit.
*p < 0.05, significantly different when compared with control.
Mice were administered Se NPs at the doses of 2.5, 5, 10 and 20 mg/kg for 14 consecutive days. No significant differences have been observed 
between the three experiment doses of 2.5, 5 and 10 mg/kg of mice groups as compared to control. All data are given as mean ± SE (n = 10).
Figure 4. Mean body weight of mice administered Se NPs at the 
doses of 2.5, 5, 10, and 20 mg/kg for 14 consecutive days.
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conclusion
Despite variations existing between species, our study 
demonstrated that Se NPs synthesized by Bacillus sp. 
MSh-1 are less toxic than synthetic Se NPs and much less 
toxic than SeO
2
. These results might be due to this fact 
that the physiochemical stability of metalloid NPs formed 
biologically by micro-organisms, are higher than that of 
NPs obtained by ordinary synthetic methods (Oremland 
et al., 2004). At present, the reason for this difference is 
not clearly known and merits further investigation.
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